clinical trial · NCT00835796
Finasteride 5 mg Tablets, Non-fasting
Teva Pharmaceuticals USA·phase1·completed·n = 20
HealthyFinasteride 5 mg tabletsPROSCAR® 5mg tablets
brief summary
The objective of this study is to compare the relative bioavailability of finasteride 5 mg tablets (manufactured and distributed by TEVA Pharmaceuticals USA) with that of PROSCAR® 5 mg tablets (Merck) in healthy, adult, non-smoking, male subjects under non-fasting conditions.
started
Jun 1, 2002
primary completion
Jul 1, 2002
completion
Jul 1, 2002
last updated
Aug 19, 2024
detailed description
Criteria for Evaluation: FDA Bioequivalence Criteria
Statistical Methods: FDA bioequivalence statistical methods
official title
A Relative Bioavailability Study of Finasteride 5 mg Tablets Under Non-Fasting Conditions
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol